Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 66

Hopper skips to $175m series G

Citi and Capital One-backed travel and accommodation marketplace platform Hopper has been valued at over $3.5bn through its series G round.

Aug 19, 2021

Danggeun draws in $162m for series D

SoftBank Ventures Asia and Kakao Ventures have joined a series D round that values the hyperlocal second-hand goods marketplace at $2.7bn.

Aug 19, 2021

SoftBank delivers $160m to PatPat

PatPat has secured SoftBank Vision Fund 2 as an investor shortly after the company earlier picked up funding from investors including SIG.

Aug 19, 2021

Kovi drives to $104m series B

Prosus Group's corporate venture capital arm co-led a $104m series B round for car leasing specialist Kovi, which will drive a geographic expansion.

Aug 18, 2021

Moloco hauls in $150m series C round

Already backed by Samsung Ventures and LG Technology Ventures, machine learning adtech company Moloco raised another $150m.

Aug 18, 2021

Sightline snatches $270m at $1bn valuation

Genting Group backed the digital betting payments platform in a funding round led by Cannae Holdings, taking its valuation to over $1bn.

Aug 18, 2021

QCraft bags $100m in series A-plus funding

Meituan's Longzhu Capital vehicle contributed to a round for the driverless vehicle technology developer that followed an investment by ByteDance five months ago.

Aug 18, 2021

SoftBank helps serve Gelato with $240m

SoftBank Vision Fund 2 was among the investors in the tailor-made item platform operator’s latest round, which took its valuation past the $1bn threshold.

Aug 17, 2021

Ualá banks $350m series D at $2.45bn valuation

Softbank and Tencent backed the digital banking app provider in a series D round which will be use to boost its expansion in Argentina and Mexico, develop new products and scale up its team.

Aug 17, 2021

GentiBio jumps to $157m series A

Novartis Venture Fund returned as GentiBio raised money that will support the progress of its type 1 diabetes drug candidate toward clinical trials.

Aug 17, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here